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To compare the clinical results of conventional phacoemulsification surgery (CPS) to 
femtosecond laser (FL) assisted cataract surgery (FLACS). 
Setting 
Guy’s & St Thomas’ NHS Foundation Trust, London, UK 
Design 
Single-centre prospective randomised interventional case-controlled trial 
Methods 
400 eyes of 400 patients undergoing cataract surgery were randomised to receive 
either CPS or FLACS. FLACS was performed with a LenSx (Alcon Inc) and all 
operations were performed with an Infiniti machine (Alcon Inc). Visual acuity (VA), 
refraction, central corneal thickness (CCT) central foveal thickness (CFT), 
endothelial cell loss (ECL), and rates of intraoperative and postoperative 
complications were recorded. Quality of life outcomes were measured with 
EuroQOL’s EQ-5D and patient reported quality of vision with Cat-PROM5. 
Results  
400 eyes of 400 patients were randomised to receive CPS (n=200) or FLACS (n=200). 
3.5% of FLACS patients were not able to complete FL treatment and received CPS. 
Unaided VA (LogMAR) after CPS was 0.15±0.21 and 0.15±0.19 after FLACS (p=1), 
and pinhole corrected VA was 0.04±0.12 and 0.04±0.12 respectively (p=1). Increase 
in CCT was 13m±19 after CPS and 15m±25 after FLACS(p=0.5). ECC loss was -
9.7%±13.7 after CPS and -10.2%±13.7 after FLACS(p=0.76). Refractive mean 
spherical equivalent error was -0.14±0.60 dioptres (D) after CPS and -0.12±0.60D for 
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FLACS(p=0.74). Change in CFT was 9m±35 after CPS and 6m±35 after 
FLACS(p=0.55). Rate of posterior capsular rupture (PCR) was 3% and 0% 
respectively(p=0.03). 
Conclusions 
This study confirms, in the majority, the non-significant differences between these two 
treatment modalities notwithstanding a significant reduction in PCRs in the FLACS 
group.  
 
Word count of abstract: 248 words 
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Introduction 
 
The introduction of femto-second laser (FL) technology to allow the automation of a 
number of surgical steps within cataract extraction has been claimed to offer potential 
advantages of reduced complications and better visual outcomes through greater 
surgical precision and reproducibility1,2. However, systems to undertake FL assisted 
cataract surgery (FLACS) are expensive both to purchase and use. In a previous study 
we estimated FLACS adds £167 (approx. 220USD) to each operation within the 
context of a state-funded healthcare system3. From a public health perspective, costs 
may be mitigated by improved safety leading to increased reliability and reduced post-
operative need for additional clinical or surgical interventions, and better patient 
outcomes4.  
 
A meta-analysis of FLACS vs CPS performed by Chen et al, identified 9 randomised 
controlled trials (RCTs)1,2,5-13. Overall, they found that FLACS significantly reduced 
effective phacoemulsification time (EPT) compared to CPS. This did not translate into 
a difference in central corneal thickness or endothelial cell count at one week or 
beyond. The rates of surgical complications were similar. The post-operative corrected 
visual acuity was statistically superior in FLACS at 1 week and 6 months post-
operatively but not at 1-3 months. There was no statistically significant difference in 
uncorrected visual acuity at any time point. 
 
Fortunately for all stakeholders, the rates of complications of cataract surgery are low. 
Therefore, large studies are required to be adequately powered to investigate 
differences in safety. The largest RCT to investigate complication rates with FLACS 
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compared to CPS published to date included 200 eyes and reported one anterior 
capsular tear in the FLACS group and no events of posterior capsular rupture (PCR) 
in either group14. With such low rates of complications, such studies are often 
underpowered to detect differences in safety. The largest case control study included 
over 7000 cataract operations (3371 FLACS and 3784 CPS) and found increased risk 
of vitreous loss in the CPS group (1.4% vs 0.8%)15. 
 
A recent Cochrane Review of 16 RCTs including 1638 eyes concluded, ‘There is 
currently not enough evidence to determine the benefits and harms of laser-assisted 
cataract surgery compared with standard ultrasound cataract surgery. The evidence 
is uncertain because current studies have not been large enough to provide a reliable 
answer to this question’16. 
 
Our aim was to complete the largest RCT published to date comparing FLACS with 
CPS with the intention to inform clinical practice and health policy worldwide. As there 
have been a lack of patient reported outcome measures (PROMs) in previous RCTs, 
this study aimed to correct this by measuring quality of life with EuroQOL’s EQ-5D and 
patient reported quality of vision with Cat-PROM517,18. 
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Methods 
The study design was a prospective randomised interventional case-controlled study 
at a single University Hospital (Guy’s & St Thomas’ Hospital NHS Foundation Trust, 
London, UK) to compare FLACS with CPS (Clinicaltrials.gov registration number 
NCT02825693). The study was approved by local Research & Development and 
Cambridge South Research Ethics Committee (reference 16/EE/0180). This study 
was conducted adhering to the tenets of the Declaration of Helsinki.  
 
Patients were screened, recruited and informed consent obtained from routine 
cataract clinics by members of the trial team (HWR, VKW) as per the trial protocol 
(Version 2.0, 18/05/2016). Inclusion and exclusion criteria are listed in Error! 
Reference source not found.. Within the enrolment visit, patients had a complete 
ophthalmological examination. Only one eye per patient was enrolled to the study. 
Patients were randomised to receive CPS or FLACS in equal proportions using 
computer generated random number tables (Microsoft Excel, Microsoft Corp, 
Redmond, Washington) just prior to being offered a date for surgery. Excel Macros 
were used to perform the randomisation (this was concealed from the allocator) and 
then lock the allocation with the patient’s research information to address allocation 
bias. All patients’ treatments in this study were delivered by the National Health 
Service and were free at the point of care. At the follow up visit, if the patient failed to 
attend, the patient was contacted and offered another appointment within one week. 
If they failed to attend this, they were considered lost to follow up from the study. 
 
Outcomes reported in this study are detailed in the trial protocol (Version 2.0, 
18/05/2016). Data collection for this study occurred at the pre-operative assessment, 
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the day of surgery, and the post-operative visit scheduled at 4 weeks after surgery 
(Error! Reference source not found.). Visual acuity and any investigations 
performed (corneal topography, specular microscopy etc.) were conducted by an 
optometrist or technician (DS, PH, DD) masked to the participant’s treatment arm. 
Due to the nature of the intervention, neither the surgeon, surgical team nor the 
participant could be masked to their treatment arm. All clinical technicians and nurses 
were masked to the intervention received. Visual acuity (unaided, best corrected, and 
pinhole) was measured with a Snellen chart at 6 meters. Participants’ refractive errors 
were collected using an RK-501A Autorefractor (Nidek Co. Ltd, Aichi, Japan). 
Biometry was performed using an IOL master 500 (Carl Zeiss Meditec AG, 
Switzerland). Corneal topography and central corneal thickness (CCT) were 
determined using Pentacam (Oculus, Germany). Macular Optical Coherence 
Tomography (OCT) was performed with Spectralis SD-OCT (Heidelberg Engineering, 
Germany). Endothelial cell count (ECC) was performed with Topcon SP-3000 
Specular Microscope (Topcon Medical Systems, Oakland, NJ, USA). Visual 
comorbidities and risk factors for complications of cataract surgery were recorded 
prospectively. Risk of posterior capsular rupture (PCR) were calculated for patients 
using a composite risk calculation system19. PROMs were collected with the Cat-
PROM5 tool and QoL were assessed using the EuroQOL EQ-5D questionnaire. The 
EQ-5D consists of 2 components: 5 questions about 5 dimensions of health-related 
quality of life (mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression) which are scored as 1, 2, or 3 (1 meaning no problems and 3 
meaning extreme problems). The 5 responses are then weighted and combined to 
create a summary index with values 0-1, where 1 indicates no problems. The visual 
analogue scale is a continuous scale anchored by best imaginable and worst 
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imaginable health, with values ranging from 0 to 100 (where 100 indicates best 
possible health). EQ-5D was chosen as it is well recognized by public bodies (such 
as the National Institute for Health & Care Excellence) for comparative health 
economic analyses20. The Cat-PROM5 is a recently developed National Institute for 
Health Research (NIHR) funded questionnaire consisting of 5 questions which provide 
a Rasch calibrated psychometrically robust measure which is highly responsive to 
cataract surgery, in which a higher score indicates greater visual disability17,18.  
 
FLACS treatment was performed using the LenSx Femtosecond laser (Alcon Inc. 
Forth Worth, Tx, USA). Two surgeons (HWR, VKW) received training and full 
accreditation on the device in anticipation of this trial and performed at least 30 laser 
applications each before the trial began. The femtosecond laser was used to perform 
capsulotomy, lens fragmentation ± astigmatic keratotomies. Default laser parameters 
for all surgeons are detailed in supplementary material #1. Where the laser treatment 
could not be performed for whatever reason (e.g. repeated inability to dock, laser 
machine fault, etc.) patients underwent surgery in accordance with conventional CPS. 
Astigmatic keratotomies (FS-AKs) (within the FLACS group) or limbal relaxing 
incisions (LRIs) (within the CPS group) were offered to any patient with corneal 
astigmatism greater than 1 dioptre (D) based on corneal topography. The astigmatic 
results are presented elsewhere21. All cataract operations were performed under local 
anaesthetic. All operations were unilateral, and no other additional procedures were 
planned, other than arcuate keratotomies for the reduction of corneal astigmatism. 
 
Following FL treatment, the patient was transferred to the operating theatre for the 
remainder of the cataract extraction. Phacoemulsification was performed using the 
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Infiniti phacoemulsification machine (Alcon Inc.) Patients undergoing CPS were 
prepared for surgery in the same way as those in the laser arm. Instead of receiving 
laser pre-treatment, they were brought straight to theatre. The default IOL used for in-
the-bag placement was the Acrysof SA60AT (Alcon Inc). All operations were 
performed by surgeons who had completed at least 30 FLACS procedures (HWR, 
VKW, DOB).   
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Statistics 
Baseline characteristics were summarised for each treatment arm (Table 3). Results 
were analysed primarily as per intention to treat. Evaluators were masked to the 
participants’ treatment arm. For all evaluations of visual acuity as an outcome, patients 
with visually significant ocular co-morbidities were excluded prospectively. Snellen 
visual acuities were converted to LogMAR for analysis22. Continuous data was 
reported using means and standard deviations if data appear Gaussian. Binary data 
was reported as frequencies and percentages and evaluated with Fischer’s exact test. 
Student’s t-tests were used for parametric data. All statistical tests used a two-sided 
p value of =0.05 unless otherwise specified. Intra-operative or post-operative 
complication were defined as any event that involved unintentional trauma to an ocular 
structure, requiring additional treatment, or having a negative effect on participants' 
eyesight. EQ-5D index scores were calculated using the visual analogue score 
method calibrated for the United Kingdom. Rasch calibrated Cat-PROM5 scores 
(logits) were calculated from the questionnaire responses in accordance with the 
developer’s instructions 16. 
 
Uncorrected distance visual acuity at 4 weeks was designated as the primary outcome 
with intra- and post-operative complications, refraction, corneal thickness, endothelial 
cell loss and quality of life outcomes and patient reported quality of vision pre-
operatively and at 4 weeks after surgery selected as secondary outcomes. A priori 
calculations for sample size indicated a total sample size of 370 to have an 85% 
chance of detecting a 0.1 difference in LogMAR visual acuity and assumption of 
 =0.32 with =0.05 and a two-tailed analysis. This sample size was rounded up to 
400 to account for the possibility of patients lost to follow up.  
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Results 
427 patients were recruited to the study between August 2016 and June 2017. 27 
patients withdrew from the trial before surgery. 400 eyes of 400 patients received 
surgery between November 2016 and June 2017 (200 CPS, 200 FLACS). 9 patients 
failed to attend their follow up appointments (2.3%). 7 participants lost to follow up 
were in the CPS group compared with 2 in the FLACS group (p=0.17). Only one of 
the participants lost to follow up had had an untoward clinical event (CPS arm), 
requiring referral to vitreo-retinal colleagues, and withdrew from providing further 
information to the study team, the remainder had had uneventful clinical courses 
(further clinical information on those lost to follow up – supplementary material#2). 
Although losses to follow-up were unequal between the arms the high overall rate of 
follow-up of 97.8% suggests that possible biases resulting from unequal follow-up 
are unlikely to be important.  
  
182 (45.5%) of participants were male, 330 (82.5%) of operations were on first eyes, 
216/400 (54%) were right eye operations. The average age of patients was 70.2 ± 
10.4 years. Average pre-operative best corrected distance LogMAR visual acuity was 
0.58 ± 0.47. Patient demographics and full baseline data can be seen in Error! 
Reference source not found.. Clinical and self-reported questionnaire measures 
were similar between the 2 groups. 155/400 operations (39.0%) were on-axis and 
314/400 (78.5%) operations were performed with the main incision sited at the corneal 
limbus and 86/400 (21.5%) with clear corneal incisions. 49/400 (12.3%) of patients 
were excluded from post-operative visual acuity analysis due to pre-existing visually 
significant ocular comorbidities (FLACS n=28, CPS n=21). Cases were distributed 
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evenly between the three surgeons and between the two treatment arms (p=0.99) 
(Table 4).  
 
FL treatment was delivered successfully to 96.5% of cases. Patients receiving FLACS 
spent, a mean time of 5.9±2.0 min in the laser room. 7 cases (3.5%) were unable to 
receive FL treatment and received CPS. The reasons were as follows: repeated 
bubbles in interface/flat cornea (n=1), administrative error (n=1), patient compliance 
(n=2), and patient’s palpebral aperture too narrow (n=3). One of these patients 
suffered an intra-operative supra-choroidal haemorrhage; the others experienced 
uncomplicated operations. The average number of docking attempts was 1.3 ± 0.7 
per patient. Reasons for failed attempts at docking and details of laser treatments 
delivered can be seen in supplementary material #1. Average duration of surgical time 
was 11.7min ± 3.5 for FLACS and 14.7 ± 6.8 for CPS. 
 
Unaided VA (LogMAR) after CPS was 0.15±0.21 and 0.15±0.19 after FLACS (p=1), 
and pinhole corrected VA was 0.04±0.12 and 0.04±0.12 respectively (p=1) (Figures 
1-4). Increase in CCT was 13m±19 after CPS and 15m±25 after FLACS(p=0.5). 
ECC loss was -9.7%±13.7 after CPS and -10.2%±13.7 after FLACS (p=0.76). 
Refractive mean spherical equivalent error was -0.14±0.60 diopters (D) after CPS and 
-0.12±0.60D for FLACS (p=0.74) (Figures 5-8). Change in CFT was 9m±35 after 
CPS and 6m±35 after FLACS (p=0.55)(Table 5). Cat-PROM5 demonstrated a 
substantial shift between pre- to postoperative completions, signalling a significant 
self-reported reduction in visual difficulty following surgery which was similar in the 2 
intervention groups. The EQ5D summary index similarly reflected an improved score 
which was similar in the 2 groups. The EQ5D visual analogue score was however 
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unchanged in the FLACS group but increased in the CPS group (Table 5). There were 
no differences in total rates of intra-operative or post-operative complications (Table 
6 and Table 7). There was a significant difference in the rate of PCR with a higher rate 
occurring in the CPS group (p=0.03).   
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Discussion 
This is the largest RCT published to date comparing the safety and effectiveness of 
FLACS vs CPS including 400 eyes of 400 patients. All surgeries were performed by 3 
surgeons at a single centre who had previously completed their FLACS learning curve 
having completed at least 30 cases. Patients were reviewed at 4 weeks post-
operatively to perform clinical examination, assess for complications and gather post-
operative data. 
 
Overall, these results point overwhelmingly to an absence of clinical differences 
between FLACS and CPS (except for PCR and EQ-5D VAS), despite this study 
including a greater number of patients than any RCT preceding it. In many aspects, 
our findings are congruous with the available evidence and on occasion are in contrast 
with conventional understanding.  
 
Previously reported gains in visual acuity for FLACS tended to be early (one week 
after surgery) or late (at 6 months) but not between 1 – 3 months13,23. In this current 
study we chose to evaluate patients at 4 weeks when the majority of post-operative 
oedema and inflammation has settled. At this time point, we found no difference in the 
post-operative visual acuity between the two groups (Figures 1 and 2, Table 5). We 
did not perform an immediate post-operative evaluation, although in accordance with 
our hospital protocol all patients were contacted by telephone to report and document 
any problems. It may be the case that FLACS has superiority in the early phase due 
to reduced ultrasound energy and reduced corneal oedema resulting in faster visual 
rehabilitation, followed by equivalence in the interim, with any late differences perhaps 
due to differences in late lens decentration or posterior capsular opacification24-26. It is 
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of note that we found no differences in CCT or ECL at one month after surgery, which 
might be expected if early corneal oedema delaying visual rehabilitation was a 
significant problem. We are also currently evaluating these patients at 12 months after 
surgery to determine late differences and these results will be reported later. 
 
No differences were found in the IOP change between the two groups, As patients 
were reviewed at 4 weeks, post-operative IOP rises might have gone unnoticed. In the 
two patients seen with raised IOP post op, both were presumed due to a steroid 
response. Furthermore, no patients presented themselves to our service in the early 
post-operative phase with extremely high IOP. 
 
This is the first large scale randomised controlled trial to evaluate rates of cystoid 
macular oedema (CMO) between FLACS and CPS. Our rates of cystoid macular 
oedema were equivalent between the two groups and there was no overall difference 
in the mean change in central foveal thickness. This is in keeping with previous 
reports8,27. Of the 7 cases of CMO in this study, risk factors were prospectively 
identified for 5 cases (previous macula off retinal detachment = 1, previous epiretinal 
membrane peel = 1, previous central retinal vein occlusion = 1, epiretinal membrane 
= 2). 
 
Our study found a statistically significant increase in the rate of PCR in the CPS group. 
This is an important finding due to the associated risks of further complications in the 
post-operative phase associated with increased morbidity and cost 4,28. The Cochrane 
review of published RCTs reported an overall rate of PCR in 0/529 (0.0%) cumulative 
FLACS cases compared with 1/547 (0.1%) for CPS23. We consider the rates of PCR 
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in both those groups to be lower than expected; perhaps reflecting patient selection 
for the studies, the expertise of the surgeons, or both. The EUREQUO case control 
study compared 2814 FLACS cases with 4987 CPS and found no significant difference 
in the PCR rates of 0.4% and 0.7% (p=0.79) respectively29. The two other largest 
studies of note included a case series of over 7000 operations in the public sector in 
the US (which found a greater rate of vitreous loss in the CPS group) 15 and a case-
control study of over 4000 patients which found no significant difference in PCR 
rates30. Our study was performed in the public sector in a hospital based within an 
inner-city area of London with the accompanying demographics and high rates of co-
morbidities. Of the patients sustaining PCR in our cohort the mean composite risk 
calculation score was 2.04% (Range 0.84% - 3.13%)19, suggesting that although on 
the high side, the 3% rate in the CPS arm of our study was at least in part a reflection 
of the surgical case complexity in our patient cohort. As such, FLACS may carry more 
of an advantage in cohorts which have an existing higher rate of PCR (i.e. in tertiary 
units performing complex cataract surgery, surgeons in training, or in this case both) 
and conversely the benefits of FLACS may be more limited in simpler case-mixes. The 
benefits of FLACS for surgeons in training have been described previously31.  
 
All but one of the PCRs in the CPS group occurred during the phacoemulsification or 
segment removal stages. The lower rate of PCR in the FLACS group could imply that 
these stages of the operation are facilitated most by the FL.  The nuclear segmentation 
patterns of the FL may produce more regular nuclear segments after cracking which 
may assist the surgeon by ensuring a more reproducible stage 2. This is certainly our 
anecdotal experience and is also reflected by the shorter surgical time in the FLACS 
group. 
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It is worth noting that the difference in PCR rates was only just statistically significant. 
One more PCR in the FLACS group or one less in the CPS group would have rendered 
this result not statistically significant (and the risk of type 2 error is increased when 
analysing outcomes with smaller numbers). However, It was possible to compare 
observed rates of PCR with expected rates as this study prospectively risk stratified 
patients according to a composite risk calculation system19,28.  
 
Self-reported visual difficulty and QoL outcomes were interesting. The Cat-PROM5 
scores overall shifted significantly towards less visual difficulty with similar reductions 
in each group. The EQ5D scores likewise shifted towards better QoL postoperatively, 
with similar improvements in each group. There was a significant increase in the EQ-
5D visual analogue score after CPS compared to FLACS (p=0.02), however in the 
absence of a plausible clinical explanation or safety issue, and as we found no 
differences in the EQ-5D-3L Index Score (p=1.0) or Cat-PROM5 Calibrated Score 
(p=0.49) we cannot suggest any reason why this result is not a type 1 statistical error. 
Furthermore the EQ5D visual analogue score is known to correlate poorly with the 
impact of cataract surgery32. 
 
Our anterior capsular tear rate was greater in the FLACS group (3% vs 1.5%) but this 
was not statistically significant. Anterior capsular tear rates in other RCTs were, again, 
exceptionally low. However Abell et al. found increased risk of anterior capsular tears 
in FLACS compared with CPS, reflecting the ‘postage-stamp edge’ microanatomy of 
the capsulotomy rim9,10,26,30,33. In our anecdotal experience the FL anterior 
capsulotomy is indeed more likely to tear than a manual continuous curvilinear 
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capsulorrhexis. This resulted in each surgeon adapting their surgical technique during 
each of our learning curves i.e. not to overly stretch the capsulotomy by removing 
large and dense fragments. This is in turn facilitated by predictable capsulotomy and 
lens fragmentation sizes created by the FL. 
 
In contrast with other studies we did not find that FLACS resulted in more predictable 
refractive outcomes than CPS1,7,26. Our overall median absolute error (0.32D for 
FLACS and 0.29D for CPS) and proportions within ±0.5D, ±1.0D were similar between 
both groups and in keeping with other studies in the literature (Figures 5 and 6). 
However, in a subgroup analysis of this same study, we have shown better outcomes 
with FS-AKs compared with manual limbal relaxing incisions21. 
 
One more surprising result is that we did not realize the reduction in 
phacoemulsification energy (CDE) previously reported with FLACS (9.6 ± 7.0) 
compared with CPS (11.1 ± 9.8, p=0.08). There was a non-significant result, however 
perhaps our preference for segmentation of the cataract rather than fragmentation into 
cubes may have been a factor. 2 studies have demonstrated reduced ultrasound 
energy in FLACS, but either using a grid pattern, or segmentation with multiple 
concentric cylinders34,35. Shajari et al. recently published their findings that CDE was 
reduced in grid pattern compared with the segmentation pattern which was our 
favoured technique36. It follows therefore, that grid pattern softens the nucleus and 
permits more phacoaspiration, reducing CDE, in comparison with segmentation 
pattern which requires a nuclear disassembly technique resembling divide-and-
conquer.  
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Previous studies have indicated that incorporating a femtosecond laser can have a 
negative impact on productivity, which can largely be attributed to transfer time 
between the laser and the surgical bed37-39. While we did not directly measure this 
transfer time, we have reported on the hub-and-spoke model we used for the 
femtosecond laser service and found that this resulted in marginal gains in productivity 
in the FL group40.  
 
The limitations of this study include that many clinical outcomes were evaluated 
leading to an increased risk of type 1 statistical errors. Furthermore, RCTs are often 
underpowered for safety and complications in cataract surgery are fortunately rare 
(making it harder to meaningfully evaluate). For example, one patient randomised to 
FLACS sustained a suprachoroidal haemorrhage (SCH). A case of SCH in FLACS 
has been reported in the literature, but it is currently unknown whether supra-
physiological vacuum applied to the globe further increases the risk of this rare but 
potentially devastating complication41. The sample size required to test for such rare 
complications would be unfeasibly large. However, as this is the largest RCT published 
to date evaluating complication rates we believe this adds important information to the 
current literature, including being incorporated in future meta-analyses. 
 
This large RCT compares the clinical outcomes of FLACS and CPS and confirms, in 
the majority, the non-significant differences between these two treatment modalities 
in terms of visual, refractive and a range of other clinical and patient reported 
outcomes, while suggesting a higher rate of posterior capsular tears following 
conventional phacoemulsification.  
 




The authors would like to thank Tim Archer and Melody Ni for their help in 
reviewing the study protocol and Isabella Mullens and Justin Sung for their 
assistance in data collection.  
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Legends for figures and tables within the text 
 
Figure 1. Unaided and corrected distance visual acuity at one month after 
FLACS 
 
Figure 2. Unaided and corrected distance visual acuity at one month after CPS 
 
Figure 3. Difference between unaided and corrected distance visual acuity at 
one month after FLACS 
 
Figure 4. Unaided and corrected distance visual acuity at one month after CPS 
 
Figure 5. Spherical equivalent refractive accuracy one month after FLACS 
 
Figure 6. Spherical equivalent refractive accuracy one month after CPS 
 
Figure 7. Postoperative refractive cylinder one month after FLACS 
 
Figure 8. Spherical equivalent refractive accuracy one month after CPS 
 
 
Table 1. Inclusion and exclusion criteria for enrolment into the study 
 
Table 2. Schedule for data collection 
 
Table 3. Baseline characteristics for the two treatment arms. (D= Dioptre, 
LogMAR = logarithm of minimum angle resolution, PCR = Posterior capsule 
rupture) 
 
Table 4. Spread of operations between the three surgeons on the trial 
 
Table 5. Post operative results for the two treatment arms .(D= Dioptre, 
LogMAR = logarithm of minimum angle resolution, PCR = Posterior capsule 
rupture) 
 
Table 6. Intraoperative complications (*this patient had been randomised to 
FLACS but received CPS). 
 
Table 7. Postoperative complications (*Both patients had been randomised to 
FLACS but one had received CPS). 
 
Online Supplementary Material 1. (A). Reasons for failed individual attempts at 
docking with the patient interface of the femtosecond laser. (B). Complications 
relating to femtosecond laser delivery. (C). Details of laser procedures 
performed. N.B. 25.5% (n=51) of the conventional phacpemulsification surgery 
arm received manual limbal relaxing incisions. (D) Default laser settings for 
each surgeon. N.B. These were only the default settings and may have been 
changed as appropriate for any given case. 
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What was known 
• Meta analyses of several small randomised controlled trials (RCTs) showed 
little overall difference of visual and refractive outcomes between FLACS and 
CPS 
• Little was known on whether a difference existed regarding patient reported 
outcome measures (PROMs) after FLACS or CPS 
What this paper adds 
• This is the largest RCT to date to demonstrate non-significance in clinical 
outcomes and PROMs between FLACS and CPS 
• Furthermore there is reason to suggest that FLACS may reduce the risk of 
posterior capsular rupture. 
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